Our Goal

To generate multiple mechanistically distinct TB drug candidates sufficient to advance a drug regimen to a one-month clinical proof of concept.

Current TB regimens drive down bacterial levels quickly, but require months of treatment to rid the body of all TB.

The only way to overcome this persistence is thorough a shorter, more effective regimen.